Utilisation of cell models from patient-derived iPSCs to further understand Parkinson's Disease

Tue2  Sep03:30pm(30 mins)
Charter 2


Parkinson's disease (PD) is a progressive neurodegenerative disorder that affects more than 5 million people worldwide. Novel models are urgently needed to accelerate the discovery of disease mechanisms, drug targets and screening purposes. We have developed PD model systems using donor fibroblasts. iPSCs were generated and evaluated using both cellular and genetic analysis tools then differentiated to dopaminergic neurons and other relevant cell types to study the associated cell types involved in PD. With this work, we hope to demonstrate how systems can be developed to identify drugs that may ameliorate the processes that underlie PD, or to understand the environmental factors that impact the development of PD.

Hosted By

The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis
Event Logo Follow us on Twitter

Get the App

Get this event information on your mobile by
going to the appstore or google play and search for 'elrig'
Eventflo Home
copyright ELRIG, eventflo.co.uk, Labhoo Ltd 2003-2021